Five things to watch in markets in the week ahead
Director Elizabeth A. Garofalo of Acadia Pharmaceuticals Inc (NASDAQ:ACAD), a $4.3 billion market cap company that has delivered an impressive 57% return over the past year, sold 1,600 shares of common stock on September 2, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at weighted average prices ranging from $25.97 to $25.991, for a total transaction value of $41,560. The transaction occurred near ACAD’s 52-week high of $26.65, with the stock showing strong momentum. InvestingPro analysis reveals the company maintains excellent financial health with an overall score of 3.67/5, suggesting robust fundamentals.
Following the transaction, Garofalo directly owns 25,382 shares of Acadia Pharmaceuticals. According to InvestingPro, the company shows promising potential with 13 additional key insights available to subscribers, including detailed valuation metrics and growth forecasts. Get access to the comprehensive Pro Research Report for deeper analysis of ACAD’s market position and future prospects.
In other recent news, Acadia Pharmaceuticals reported its second-quarter financial results, with Nuplazid sales hitting $168.5 million, aligning with consensus expectations. The company also saw Daybue sales of $96.1 million, surpassing consensus estimates. Following these results, Mizuho raised its price target for Acadia Pharmaceuticals to $24 from $23, maintaining a Neutral rating. Stifel also increased its price target to $24 from $18, citing solid execution of Nuplazid and Daybue, while maintaining a Hold rating. Citizens JMP went further, raising its price target to $38 from $37, noting that the financial results exceeded both its and consensus estimates. In personnel news, Acadia Pharmaceuticals appointed Konstantina "Tina" Katcheves as Senior Vice President, Chief Business and Strategy Officer. Katcheves will lead business development and corporate strategy, reporting directly to CEO Catherine Owen Adams. These developments highlight recent strategic and financial activities within the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.